FDA clears first CRISPR treatment for a second disease, beta thalassemia ...Middle East

By Brenda Goodman, CNN (CNN) — The US Food and Drug Administration has approved a second use for the first CRISPR-based medicine, Casgevy, which was approved in December to treat sickle cell disease. The groundbreaking treatment can now also be used to treat transfusion-dependent beta thalassemia in people 12 and older. Like sickle cell, beta thalassemia is an inherited blood disorder. The FDA’s decision was expected, but it comes about two months earlier than the agency’s deadline for acting, called the PDUFA date. To make Casgevy, a person’s stem cells are genetically modified using a precision gene editing technique called CRISPR/Cas9.  The modified cells are then transplanted ba

Hence then, the article about fda clears first crispr treatment for a second disease beta thalassemia was published today ( Wednesday 17/01/2024 - 03:37 AM ) and is available on News channel ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA clears first CRISPR treatment for a second disease, beta thalassemia )

Also on site :

• Matt Damon’s Recent Rap Debut Was for Charity, Not a Career Pivot: ‘Kendrick Has Nothing to Worry About’
• Nothing sticks to John Bolton
• 1972 Rock Song, Never a No. 1 Hit, Remains a Radio Classic 54 Years Later